Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1-Reference-Cited by-同舟云学术

Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1

Published:2018-03-14 Issue:5 Volume:81 Page:863-872
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Yin Peng,Song Guizhen,Jiang Zhenhua

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-018-3536-5/fulltext.html

Reference53 articles.

1. Cui Q, Feng FT, Xu M, Liu WS, Yao YY, Xie SH, Li XZ, Ye ZL, Feng QS, Chen LZ, Bei JX, Feng L, Huang QH, Jia WH, Cao SM, Chang ET, Ye W, Adami HO, Zeng YX (2016) Nasopharyngeal carcinoma risk prediction via salivary detection of host and Epstein–Barr virus genetic variants. Oncotarget. https://doi.org/10.18632/oncotarget.11144

2. Jin GQ, Yang J, Liu LD, Su DK, Wang DP, Zhao SF, Liao ZL (2016) The diagnostic value of 1.5-T diffusion-weighted MR imaging in detecting 5–10 mm metastatic cervical lymph nodes of nasopharyngeal carcinoma. Medicine 95(32):e4286. https://doi.org/10.1097/md.0000000000004286

3. Lu L, Li J, Zhao C, Xue W, Han F, Tao T, Chang H, Jia W, Lu T (2016) Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma. Oral Oncol 60:18–24. https://doi.org/10.1016/j.oraloncology.2016.06.013

4. Maingon P, Blanchard P, Bidault F, Calmels L (2016) Radiotherapy for nasopharyngeal carcinoma. Cancer radiotherapie: journal de la Societe francaise de radiotherapie oncologique. https://doi.org/10.1016/j.canrad.2016.07.031

5. Yao K, Yang S, Shen J, Zhang R, Li L (2016) HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: a meta-analysis. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc (EUFOS) Affil German Soc Oto-Rhino-Laryngol Head Neck Surg. https://doi.org/10.1007/s00405-016-4264-2

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC;Anticancer Research;2022-07

2. Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells;Dalton Transactions;2022

3. Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research;International Journal of Molecular Sciences;2020-11-13

4. Lgr5 maintains stemness and regulates cell property in nasopharyngeal carcinoma through Wnt/β-catenin signaling pathway;Stem Cell Research;2020-08

5. ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway;Translational Cancer Research;2020-05